Access cutting-edge breast cancer treatment through this clinical trial at a research site in San Marcos. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in San Marcos at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This study will evaluate the efficacy and safety of the combination of inavolisib plus a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) and letrozole versus placebo plus a CDK4/6i and letrozole in the first-line setting in participants with endocrine-sensitive PIK3CA-mutated hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), advanced breast cancer (ABC).
Sponsor: Hoffmann-La Roche
Check if you qualify for this breast cancer clinical trial in San Marcos, CA
If you're searching for breast cancer treatment options in San Marcos, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Marcos research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.